NAME CTS AFFILIATION DISCLOSURE UPDATED

Transcription

1 NAME CTS AFFILIATION DISCLOSURE UPDATED Darcy Marciniuk (Chair) and Canadian and Canadian COPD Alliance Consultant Fee, Speaker s Bureau, Advisory Committee: AstraZeneca, Boehringer-Ingelheim, Canadian Agency for Drugs and Technologies in Health, GlaxoSmithKline, Health Canada, Health Quality Council of Saskatchewan, Novartis, Nycomed, Pfizer, Prince Albert Grand Council Chronic Disease Network, Public Health Agency of Canada, Saskatoon Health Region Fiduciary Position (other than CTS or CRHP): American College of Chest Physicians, Chest Foundation, Lung Association of Saskatchewan Research/Program Grant Funding: AstraZeneca, Boehringer- Ingelheim, Canadian Institutes of Health Research, GlaxoSmithKline, Lung Association of Saskatchewan, Novartis, Pfizer, Public Health Agency of Canada, Royal University Hospital Foundation, Saskatchewan Health Research Foundation, Saskatchewan Ministry of Health, Schering-Plough March 14 th, Shawn Aaron May 13 th, 2010 Advisory Board: AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline Consultant: Health Canada Therapeutic Products Directorate, Ontario Ministry of Health and Long Term Care Pat Bailey Over the last two years, I have NOT had any affiliations (financial or otherwise) with a commercial or other organization that could lead to a real or perceived Jan 7 th, Meyer Balter and Canadian Advisory Board: AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, Merck, Novartis, Nycomed, Pfizer Speaker: AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, Merck Frosst, Nycomed, Pfizer May 4 th, 2010

2 Donna Bleakney External Reviewer Over the last two years, I have not had any affiliation (financial or otherwise) Dina Brooks and Canadian COPD Alliance and CRC Planning Committee Over the last two years, I have not had any affiliation (financial or otherwise) conflict of interest Scott Butcher Over the last two years, I have not had any affiliation (financial or otherwise) Richard Debigare Over the last two years, I have not had any affiliation (financial or otherwise) Gail Dechman Research/Program Grant Funding: Dalhousie University, Lung Association of Nova Scotia, Nova Scotia Health Research Foundation, Social Sciences and Humanities Research Council Membership (other than CTS or CRHP): ATS, AACVPR, Canadian Physiotherapy Association, Nova Scotia College of Physiotherapy, Nova Scotia Physiotherapy Association May 12 th, 2010 May 12 th, 2010 Gordon Ford Advisory Board and Honoraria: Abbott, Astra Zeneca, Boehringer- Ingelheim, GlaxoSmithKline, Nycomed, Pfizer, Janssen-Ortho Inc. Appointment: Medical staff, Alberta Health Services Research/Program Grant Funding: Astra Zeneca, Boehringer- Ingelheim, GlaxoSmithKline, Nycomed, Pfizer July 21 st, 2010 Donna Goodridge Appointment: University of Saskatchewan, Associate Professor, College of Nursing Speaker: Lilly (sponsored her to attend educational session on depression in COPD for primary care physicians, Sept. 2009) 1

3 Paul Hernandez and Canadian and Pulmonary Vascular Disease Committee and Canadian COPD Alliance Advisory Board and Consultant: AstraZeneca, Actelion, Boehringer- Ingelheim, GlaxoSmithKline, Lilly, Merck Frosst, Novartis, Nycomed, Pfizer CME Development and Speaker: AstraZeneca, Actelion, Boehringer- Ingelheim, GlaxoSmithKline, Pfizer, Canadian Conference, Atlantic Respirology and Critical Care Conference Medical Advisory Board: Lung Association of Nova Scotia, Canadian COPD Alliance Research/Program Grant Funding: AstraZeneca, Actelion, Boehringer- Ingelheim, CSL Behring, GlaxoSmithKline, Lilly, Novartis, Nycomed, Pfizer, Lung Association of Nova Scotia, Canadian Institute of Health Research, Capital Health Research Foundation Reviewer and Consultant: Canadian Agency for Drugs and Technologies in Health Vicki Kennedy Over the last two years, I have not had any affiliation (financial or otherwise) Julie Lauzon (A1AT) Appointment: Clinical staff, University of Calgary Dec 7 th, Francois Maltais Advisory Board: Boehringer-Ingelheim, GlaxoSmithKline Research/Program Grant Funding: Altana Pharma, Astra Zeneca, Boehringer-Ingelheim, GlaxoSmithKline, Merck Frosst, Novartis, Nycomed Research Chair in COPD: Canadian Institutes of Health Research and GlaxoSmithKline Speaker: Boehringer-Ingelheim, GlaxoSmithKline, Pfizer

4 Denis O Donnell and past President of the Canadian Thoracic Society Advisory Board: Boehringer-Ingleheim, Pfizer Canada Consulting Fees and Speaker Bureau/Honoraria: Boehringer- Ingelheim, GlaxoSmithKline, Pfizer Canada Research/Program Grant Funding: Boehringer-Ingelheim, GlaxoSmithKline, Novartis, Pfizer. Veronique Pepin May 2 nd, 2010 Advisory Board and Speaker: GlaxoSmithKline Research/Program Grant Funding: GlaxoSmithKline, Canadian Institutes of Health Research, Canadian Lung Association, Fonds de la recherche en santé du Québec, Reviewer: Fonds de la recherche en santé du Québec Darlene Reid Over the last two years, I have not had any affiliation (financial or otherwise) Graeme Rocker May 3 rd, 2010 Advisory Board: Canadian Institutes of Health Research (Panel Scientific Officer) Speaker: GlaxoSmithKline, various Universities, Pfizer (Canada, USA, UK) Research/Program Grant Funding: Canadian Institutes of Health Research, Capital Health, CHEST foundation, Lung Association of Nova Scotia, GlaxoSmithKline, Medical Research Fund New Brunswick, Atlantic Health Sciences Corporation Reviewer or Consultant: CIHR, CMAJ, CHEST, Progress in Palliative Care, J Palliat Care, J Pain Sympt Manage, Annals Intern Med, Guest Editor, J Palliat Care and Progress in Palliat Care

5 William Sheel Over the last two years, I have not had any affiliation (financial or otherwise) Michael Stickland May 4 th, 2010 May 9 th, 2010 Appointment: Co-director of the Centre for Lung Health, Covenant Health, Edmonton, Alberta Research/Program Grant Funding: GlaxoSmithKline, Heart and Stroke Foundation of Canada, Canadian Institutes for Health Research, Alberta Lung Association Speaker: GlaxoSmithKline David Todd Research/Program Grant Funding: AstraZeneca, Ontario Thoracic Society Shannon Walker and Membership April 28 th, 2010 Advisory Board: AstraZeneca, GlaxoSmithKline, Nycomed Appointments: On-call services, Flame Oxygen, ICU Director, Cardiopulmonary Wellness Center at InterHealth (BC),UBC teacher for residents and medical students Consultant: Boehringer-Ingelheim Speaker: AstraZeneca, BC College of Family Physicians, BC College of Therapists, Boehringer-Ingelheim, GlaxoSmithKline, Nycomed, Pfizer